Article Sidebar

pdf
Date Published: 29/10/2024
Abstract Views: 285
Views pdf: 132
DOI: https://doi.org/10.51298/vmj.v543i3.11573
Issue
Vol. 543 No. 3 (2024)
Section
Các bài báo
How to Cite
Lưu, T. A., Trần, D. H., & Trần, N. Ánh. (2024). THE PREVALENCE OF PORTAL HYPERTENSIVE GASTROPATHY USING BAVENO CLASSIFICATION ON CIRRHOTIC PATIENTS AND ASSOCIATED FACTORS. Vietnam Medical Journal, 543(3). https://doi.org/10.51298/vmj.v543i3.11573

THE PREVALENCE OF PORTAL HYPERTENSIVE GASTROPATHY USING BAVENO CLASSIFICATION ON CIRRHOTIC PATIENTS AND ASSOCIATED FACTORS

Tuấn Anh Lưu, Duy Hưng Trần, Ngọc Ánh Trần

Main Article Content

Abstract

Aims: evaluate the prevalence of portal hypertensive gastropathy (PHG) based on Baveno classification among patients with cirrhosis and associated factors. Subjects and methods: a cross-sectional study was conducted among 223 patients with cirrhosis at the Department of Internal Medicine – Hanoi Medical University Hospital between 08/2023 and 03/2024. Our study used Baveno classification to assess PGH on endoscopy, mild PHG when total score ≤3 and severe when total score >3. Result: The mean age was 57.7 ± 10.4, 87% of patients were men. The most common etiologies of cirrhosis are alcohol (62.8%), hepatitis B virus (32.3%), and hepatitis C virus (5.8%). The prevalence of PHG was 50.2% including 28.3 mild PHG and 32.5% severe PHG. Associated factors with the severity of PHG was sex, collateral circulation, the severity of anemia, PT%, Child-Pugh grade, portal vein dilation, and esophageal varices. Conclusion: 50.2% of cirrhotic patients were presented with PHG on endoscopy and 21.9% of them had severe PHG. The main predictive factors of PHG were the presence of portal hypertension and the severity of cirrhosis

Article Details

Keywords

portal hypertensive gastropathy, cirrhosis, Baveno

References

1. Chalasani, N., et al., The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 2018. 67(1): p. 328-357.
2. Gunarathne, L.S., et al., Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol, 2020. 26(40): p. 6111-6140.
3. Pozzan, R., et al., Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes. Arch Endocrinol Metab, 2022. 66(4): p. 452-458.
4. Gjeorgjievski, M. and M.S. Cappell, Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy. World J Hepatol, 2016. 8(4): p. 231-62.
5. Eid, K.-A., et al., Prevalence of Helicobacter pylori infection in patients with portal hypertensive gastropathy owing to liver cirrhosis in Upper Egypt. Al-Azhar Assiut Medical Journal, 2016. 14: p. 109.
6. Miyaaki, H., et al., Endoscopic management of esophagogastric varices in Japan. Ann Transl Med, 2014. 2(5): p. 42.
7. Nishino, K., et al., Portal Hypertensive Gastropathy in Liver Cirrhosis: Prevalence, Natural History, and Risk Factors. Intern Med, 2022. 61(5): p. 605-613.
8. Wu, R., et al., Risk factors for portal hypertensive gastropathy. BMC Gastroenterology, 2022. 22(1): p. 436.
9. Tiwari, P.S., et al., Prevalence of Portal Hypertensive Gastropathy in Chronic Liver Disease and Correlation with the Severity of Liver disease. Cureus, 2019. 11(8): p. e5454.
10. Cubillas, R. and D.C. Rockey, Portal hypertensive gastropathy: a review. Liver Int, 2010. 30(8): p. 1094-102.